Meropenem Basics

Meropenem, the active ingredient in Meropenem Basics, is a carbapenem antibiotic presented as a (strength/form) for intravenous use. It treats serious bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, hospital‑acquired pneumonia, severe sepsis and meningitis in hospitalized patients.

GNH USA supplies Meropenem Basics as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem used for severe bacterial infections affecting various organ systems. - Complicated intra‑abdominal infections: provides bacterial eradication and clinical cure. - Complicated urinary tract infections: eliminates resistant Gram‑negative pathogens. - Hospital‑acquired pneumonia: treats multidrug‑resistant organisms causing lower respiratory infection. - Severe sepsis: offers rapid bactericidal activity in systemic infection. - Bacterial meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria.

Adverse reactions may occur with any intravenous antibiotic and should be monitored during therapy.

Common Side Effects: - Diarrhea: mild to moderate gastrointestinal upset. - Nausea: occasional feeling of queasiness. - Headache: transient cranial discomfort. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases. - Phlebitis: irritation at infusion site.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: particularly in patients with renal impairment or CNS disorders. - Clostridioides difficile infection: colitis due to disruption of normal flora. - Hemolytic anemia: rare immune‑mediated red cell destruction. - Neutropenia: significant drop in white blood cell count. - Renal dysfunction: worsening kidney function in susceptible individuals.

Use meropenem only under medical supervision, considering patient‑specific factors and potential risks. - Renal impairment: adjust dose based on creatinine clearance. - CNS disorders: monitor for seizures, especially in patients with a history of epilepsy. - Hypersensitivity: avoid if known allergy to carbapenems or other β‑lactams. - Pregnancy and lactation: assess risk‑benefit ratio; limited data available. - Concomitant nephrotoxic drugs: increase monitoring of renal function. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid): - Valproic acid: risk of reduced seizure control; consider alternative therapy. - Probenecid: may increase meropenem plasma concentrations, raising toxicity risk.

Moderate Interactions (Monitor Closely): - Aminoglycosides: additive nephrotoxicity; monitor renal function. - Loop diuretics: potential for increased ototoxicity when combined with other ototoxic agents. - Warfarin: possible alteration of INR; check coagulation parameters regularly. - Oral contraceptives: may reduce effectiveness; advise additional contraceptive measures.